8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Young Minds: Mental Health and Transitional Care in Adolescent and Young Adult Rheumatology

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Consideration of the mental health and emotional wellbeing is an important component of health care for all young people, irrespective of setting. Mental health disorders are common during adolescence and young adulthood and young people with rheumatic musculoskeletal diseases (RMD) are not exempt. For such young people, risks of poor outcomes are related to both mental health as well as their RMD. Times of change during adolescence and young adulthood—transitions—are potentially vulnerable life stages for young people with RMD and warrant specific attention in health care provision. Such transitions include those occurring at puberty, during education, training, and employment, socially with moves away from the parental home, as well as from child to adult-centered health services. There is great potential for rheumatology professionals to support young people with RMD at these transitions in view of their frequent encounters and ongoing therapeutic relationships. In this review, we aim to assess the impact of mental health on RMD during adolescence and young adulthood with particular reference to transitional care provision and how rheumatology professionals can be involved in addressing mental health issues during this time of change.

          Related collections

          Most cited references112

          • Record: found
          • Abstract: found
          • Article: not found

          Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

          Little is known about lifetime prevalence or age of onset of DSM-IV disorders. To estimate lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the recently completed National Comorbidity Survey Replication. Nationally representative face-to-face household survey conducted between February 2001 and April 2003 using the fully structured World Health Organization World Mental Health Survey version of the Composite International Diagnostic Interview. Nine thousand two hundred eighty-two English-speaking respondents aged 18 years and older. Lifetime DSM-IV anxiety, mood, impulse-control, and substance use disorders. Lifetime prevalence estimates are as follows: anxiety disorders, 28.8%; mood disorders, 20.8%; impulse-control disorders, 24.8%; substance use disorders, 14.6%; any disorder, 46.4%. Median age of onset is much earlier for anxiety (11 years) and impulse-control (11 years) disorders than for substance use (20 years) and mood (30 years) disorders. Half of all lifetime cases start by age 14 years and three fourths by age 24 years. Later onsets are mostly of comorbid conditions, with estimated lifetime risk of any disorder at age 75 years (50.8%) only slightly higher than observed lifetime prevalence (46.4%). Lifetime prevalence estimates are higher in recent cohorts than in earlier cohorts and have fairly stable intercohort differences across the life course that vary in substantively plausible ways among sociodemographic subgroups. About half of Americans will meet the criteria for a DSM-IV disorder sometime in their life, with first onset usually in childhood or adolescence. Interventions aimed at prevention or early treatment need to focus on youth.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The Strengths and Difficulties Questionnaire: A Research Note

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Depression in adolescence.

              Unipolar depressive disorder in adolescence is common worldwide but often unrecognised. The incidence, notably in girls, rises sharply after puberty and, by the end of adolescence, the 1 year prevalence rate exceeds 4%. The burden is highest in low-income and middle-income countries. Depression is associated with substantial present and future morbidity, and heightens suicide risk. The strongest risk factors for depression in adolescents are a family history of depression and exposure to psychosocial stress. Inherited risks, developmental factors, sex hormones, and psychosocial adversity interact to increase risk through hormonal factors and associated perturbed neural pathways. Although many similarities between depression in adolescence and depression in adulthood exist, in adolescents the use of antidepressants is of concern and opinions about clinical management are divided. Effective treatments are available, but choices are dependent on depression severity and available resources. Prevention strategies targeted at high-risk groups are promising. Copyright © 2012 Elsevier Ltd. All rights reserved.
                Bookmark

                Author and article information

                Journal
                Open Access Rheumatol
                Open Access Rheumatol
                oarrr
                rheu
                Open Access Rheumatology : Research and Reviews
                Dove
                1179-156X
                07 December 2020
                2020
                : 12
                : 309-321
                Affiliations
                [1 ]Department of Paediatric and Adolescent Rheumatology, Royal Manchester Children’s Hospital, Manchester University Hospitals NHS Trust , Manchester M13 9WL, UK
                [2 ]Versus Arthritis Centre for Epidemiology; Centre for MSK Research, University of Manchester , Manchester, UK
                [3 ]NIHR Biomedical Research Centre, Manchester University Hospital NHS Trust , Manchester, UK
                Author notes
                Correspondence: Janet E McDonagh Centre for MSK Research, University of Manchester , Stopford Building, 2nd Floor, Oxford Road, ManchesterM13 9PTUKTel +44 161 275 1670 Email janet.mcdonagh@manchester.ac.uk
                Author information
                http://orcid.org/0000-0001-6783-4235
                http://orcid.org/0000-0002-4555-7270
                Article
                228083
                10.2147/OARRR.S228083
                7732171
                33324121
                97bd0e02-c866-4a3f-aac1-6b8ebba3d913
                © 2020 Palman and McDonagh.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 25 July 2020
                : 11 November 2020
                Page count
                Figures: 0, Tables: 3, References: 114, Pages: 13
                Funding
                Funded by: no funding;
                JMcD is supported by Versus Arthritis Centre for Epidemiology (UK grant No: 21755) and the NIHR Manchester Biomedical Research Centre.
                Categories
                Review

                adolescent,young adult,developmentally appropriate health care,transitional care,rheumatology,rheumatic musculoskeletal disease,mental health

                Comments

                Comment on this article